期刊文献+

分子影像技术活体追踪移植干细胞的研究进展 被引量:2

Advances of in vivo stem cell tracking with molecular imaging
在线阅读 下载PDF
导出
摘要 干细胞具有分化、再生能力,通过体外扩增和体内移植,可以治疗各种组织坏损和退化性疾病(如心脑血管疾病、脑脊髓外伤和糖尿病等),具有极大的应用前景,是目前国际、国内的研究热点。利用核素显像、磁共振成像和光成像等分子影像技术,通过体外直接标记、报告基因或功能显示等追踪策略,可以显示干细胞在活体内的分布和变化,明确其最终归宿和产生的功能。合理选择这些分子影像技术和追踪策略,或通过互补结合,将有助于阐明干细胞在活体内的作用机制和相关的影响因素,指导临床干细胞治疗抉择和疗效评估。 Stem cell therapy is a hot topic of current medical research. By ex vivo expansion and in vivo transplantation, stem cells can be taken as a regenerative "pharmaceutical", and hold promise to treat various diseases with tissue damage or cell loss, such as cardiovascular disease, diabetes mellitus, and some brain diseases. Molecular imaging, including radionuclide imaging, magnetic resonance imaging, and optical imaging, has been playing an important role in monitoring and evaluating stem cell therapy. The tracking strategies, such as direct labeling of stem cells, reporter gene techniques, and functional characterization of targets, can help to reveal the distribution, homing, and destiny of stem cells in vivo, and evaluate the resumed function of target organs or tissues. In this article, we reviewed the new advances of the field, and discussed the advantages and weakness of related techniques.
作者 朱朝晖
出处 《现代仪器》 2007年第4期6-8,5,共4页 Modern Instruments
关键词 干细胞 分子影像 核素显像 磁共振成像 光成像 Stem cell In vivo tracking Radionuclide imaging Magnetic resonance imaging Optical imaging
  • 相关文献

参考文献16

  • 1Shanthley N,Aruva MR,Zhang K,et al.Stem cells:A regenerative pharmaceutical.Q J Nucl Med Mol Imaging.2006,50:205 - 16
  • 2Fang B,Shi M,Liao L,et al.Multiorgan engraftment and multilineage differentiation by human fetal bone marrow Flk1 +/CD31-/CD34-Progenitors.J Hematother Stem Cell Res.2003,12(6):603 - 13
  • 3朱朝晖.分子影像学与蛋白质组学[J].现代仪器,2006,12(4):1-3. 被引量:3
  • 4朱朝晖.正电子发射断层显像[J].现代仪器,2001,37(1):14-17. 被引量:16
  • 5San Roman JA,Fernandez-Aviles F.The role of noninvasive imaging techniques in the assessment of stem cell therapy after acute myocardial infarction.Nature Clin Prac Cardiovasc Med.2006,3:S38 - S41
  • 6Frangioni JV,Hajjar RJ.In vivo tracking of stem cells for clinical trails in cardiovascular disease.Circulation.2004,110:3378 - 84
  • 7朱朝晖.PET-CT技术的发展现状与展望[J].现代仪器,2004,10(4):6-11. 被引量:30
  • 8丁为民,何义杰,田嘉禾.核素干细胞活体示踪[J].核技术,2004,27(11):861-864. 被引量:3
  • 9Gao J,Dennis JE,Muzic RF,et al.The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion.Cells Tissues Organs.2001,169:12 - 20
  • 10Hofmann M,Wollert KC,Meyer GP,et al.Monitoring of bone marrow cell homing into the infarcted human myocardium.Circulation.2005,111:2198 - 202

二级参考文献129

  • 1朱朝晖.PET-CT技术的发展现状与展望[J].现代仪器,2004,10(4):6-11. 被引量:30
  • 2徐光辉,白金柱,蔡钦林,李肖霞,李凌松,沈丽.Effect of human neural progenitor cells on injured spinal cord[J].Chinese Journal of Traumatology,2005,8(6):339-344. 被引量:1
  • 3[1]Oshiro M. Methods Cell Bio1,1998,56(1):45-62
  • 4[2]Phelps M E. Neurochem Res, 1991,16(9):929-940
  • 5[3]Zhang Z G , Jiang Q, Zhang R, et al. Ann Neurol,2003,53(2):259-263
  • 6[4]Orlic D, Hill J M, Arai A E. Circ Res, 2002, 91(12): 1092-1102
  • 7[5]Modo M, Cash D, Mellodew K. et al. Neuroimage,2002,17(2): 803-811
  • 8[6]Bulte J W, Duncan I D, Frank J A. J Cereb Blood Flow Metab, 2002, 22 (8):899-907
  • 9[7]Bjorklund L M, Sanchez-Pernaute R, Chung S, et al. Proc Natl Acad Sci USA,2002, 99(4):2344-2349
  • 10[8]Bergstrom M, Fasth K J, Kilpatrick G, et al.Neuropharmacology, 2000, 39(4):664-670

共引文献51

同被引文献52

  • 1徐高连,赵冰海,吕学诜.NIH医学研究路线图(NIH roadmap)[J].黑龙江医药科学,2005,28(4):60-61. 被引量:5
  • 2朱朝晖.分子影像学与蛋白质组学[J].现代仪器,2006,12(4):1-3. 被引量:3
  • 3DiMasi J, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. J Health Econ. 2003, 22(2): 151-185.
  • 4Yang JY, Yang MQ, Arabnia HR, et al. Genomics, molecular imaging, bioinformatics, and bio-nano-info integration are synergistic components of translational medicine and personalized healthcare research. BMC Genomics 2008, 9 (Suppl 2): 11.
  • 5Wehling M. Translational medicine: can it really facilitate the transition of research "from bench to bedside" . Eur J Clin Pharmacol. 2006, 62(2):91-5.
  • 6Marincola FM: Translational medicine: a two way road. J Transl Med 2003,1 (1): 1-2.
  • 7Weissleder R. Molecular imaging: exploring the next frontier. Radiology. 1999, 212(3): 609-614.
  • 8Pomper MG. Translational molecular imaging for cancer. Cancer Imaging. 2005,5(Spec No A): S 16-S26.
  • 9Bayele HK, Chiti A, Colina R, et al. Isotopic biomarker discovery and application in translational medicine. Drug Discovery Today, 2010, 15(3/4): 127-137.
  • 10Tseng JC, Zanzonico PB, Levin B, et al. Tumor-specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J Nucl Med. 2006, 47(7): 1136-1143.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部